Amirhossein Sahebkar
Impact in
- Molecular Medicine top 0.01%
- Curcumin's Biomedical Applications
- Biochemistry top 0.05%
- Phytochemicals and Antioxidant Activities
Papers in
-
- RNA Interference and Gene Delivery 81
-
- Curcumin's Biomedical Applications 291
- Co-authors
- Maciej Banach (214 shared papers)Yunes Panahi (115 shared papers)Habib Yaribeygi (96 shared papers)Tannaz Jamialahmadi (251 shared papers)Thomas P. Johnston (96 shared papers)Matteo Pirro (107 shared papers)Stephen L. Atkin (95 shared papers)Alexandra E. Butler (83 shared papers)
- Journals
- Advances in experimental medicine and biology (116 papers)Journal of Cellular Physiology (100 papers)Current Medicinal Chemistry (94 papers)Pharmacological Research (63 papers)Phytotherapy Research (58 papers)
- Partner nations
- IranAustraliaUnited States
In The Last Decade
Amirhossein Sahebkar
1.9k papers receiving 73.2k citations
Amirhossein Sahebkar's Hit Papers
Peers
Comparison fields: 5 of 219
- Molecular Medicine 12.1k
- Biochemistry 3.0k
- Pharmacology 3.6k
- Cancer Research 5.9k
- Complementary and alternative medicine 3.1k
Countries citing papers authored by Amirhossein Sahebkar
This map shows the geographic impact of Amirhossein Sahebkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amirhossein Sahebkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amirhossein Sahebkar more than expected).
Fields of papers citing papers by Amirhossein Sahebkar
This network shows the impact of papers produced by Amirhossein Sahebkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amirhossein Sahebkar. The network helps show where Amirhossein Sahebkar may publish in the future.
Co-authors
The 25 scholars most cited alongside Amirhossein Sahebkar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 2.0k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Macrophage plasticity, polarization, and function in health and disease Hit paper breakdown → | 2018 | 3864 |
| 2 | The impact of stress on body function: a review Hit paper breakdown → | 2017 | 758 |
| 3 | Insulin resistance: Review of the underlying molecular mechanisms Hit paper breakdown → | 2018 | 687 |
| 4 | Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus Hit paper breakdown → | 2020 | 496 |
| 5 | Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review Hit paper breakdown → | 2018 | 451 |
| 6 | Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies Hit paper breakdown → | 2016 | 448 |
| 7 | NLRP3 inflammasome: Its regulation and involvement in atherosclerosis Hit paper breakdown → | 2017 | 397 |
| 8 | Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial Hit paper breakdown → | 2016 | 388 |
| 9 | Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis Hit paper breakdown → | 2015 | 365 |
| 10 | Role of the NLRP3 inflammasome in cancer Hit paper breakdown → | 2018 | 347 |
| 11 | 2019 | 336 | |
| 12 | 2017 | 332 | |
| 13 | Melissa officinalis L. – A review of its traditional uses, phytochemistry and pharmacology Hit paper breakdown → | 2016 | 298 |
| 14 | 2019 | 289 | |
| 15 | Prevalence of statin intolerance: a meta-analysis Hit paper breakdown → | 2022 | 282 |
| 16 | 2013 | 281 | |
| 17 | 2020 | 274 | |
| 18 | 2016 | 272 | |
| 19 | Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways Hit paper breakdown → | 2020 | 270 |
| 20 | 2016 | 261 |
About Amirhossein Sahebkar
Amirhossein Sahebkar is a scholar working on Molecular Biology, Molecular Medicine, Surgery, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 2.0k papers that have together received 74.5k indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (291 papers), Lipoproteins and Cardiovascular Health (156 papers), MicroRNA in disease regulation (85 papers), RNA Interference and Gene Delivery (81 papers), Cancer, Lipids, and Metabolism (58 papers), Nanoparticle-Based Drug Delivery (55 papers), COVID-19 Clinical Research Studies (54 papers) and Atherosclerosis and Cardiovascular Diseases (54 papers). The work is most often cited by research in Molecular Medicine (12.1k citations), Biochemistry (3.0k citations), Pharmacology (3.6k citations), Cancer Research (5.9k citations) and Complementary and alternative medicine (3.1k citations). Amirhossein Sahebkar has collaborated with scholars based in Iran, Australia and United States. Frequent co-authors include Maciej Banach, Yunes Panahi, Habib Yaribeygi, Tannaz Jamialahmadi, Thomas P. Johnston, Matteo Pirro, Stephen L. Atkin, Alexandra E. Butler, Muhammed Majeed and Thozhukat Sathyapalan. Their work appears in journals such as Advances in experimental medicine and biology, Journal of Cellular Physiology, Current Medicinal Chemistry, Pharmacological Research and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.